EMEA-000986-PIP02-13

Key facts

Invented name
Jetrea
Active substance
ocriplasmin
Therapeutic area
Ophthalmology
Decision number
P/0049/2014
PIP number
EMEA-000986-PIP02-13
Pharmaceutical form(s)
Concentrate for solution for injection
Condition(s) / indication(s)
Treatment of symptomatic focal vitreomacular adhesion
Route(s) of administration
Intravitreal use
Contact for public enquiries
ThromboGenics NV 
Belgium 
E-mail: info@thrombogenics.com
Tel. +32 16751310
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating